ECSP003814A - INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY. - Google Patents

INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.

Info

Publication number
ECSP003814A
ECSP003814A ECSP003814A ECSP003814A EC SP003814 A ECSP003814 A EC SP003814A EC SP003814 A ECSP003814 A EC SP003814A EC SP003814 A ECSP003814 A EC SP003814A
Authority
EC
Ecuador
Prior art keywords
dependent
inhibitors
diabetic retinopathy
aminotranspherase
treatment
Prior art date
Application number
Other languages
Spanish (es)
Inventor
David Juergen Wustrow
Lain-Yen Hu
Michael Francis Rafferty
Susan M Hutson
Erich Lieth
Todd Robert Ryder
Devin Franklin Welty
Kathryn Foley Lanoue
Ti-Zhi Su
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003814 priority Critical patent/ECSP003814A/en
Publication of ECSP003814A publication Critical patent/ECSP003814A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un método para el tratamiento profiláctico y terapéutico de la retinopatía diabética. El método consiste en la administración de un inhibidor de la vía de la aminotransferasa dependiente de aminoácido de cadena ramificada (BCAT), a un animal, tal como un mamífero, en particular un humano, en una cantidad suficiente para tratar profiláctica y terapéuticamente la retinopatía diabética. La presente invención también se refiere a varios inhibidores novedosos de la vía de la BCAT.The present invention relates to a method for the prophylactic and therapeutic treatment of diabetic retinopathy. The method consists in the administration of a branched-chain amino acid-dependent aminotransferase (BCAT) inhibitor to an animal, such as a mammal, in particular a human, in an amount sufficient to prophylactically and therapeutically treat retinopathy. diabetic The present invention also relates to several novel inhibitors of the BCAT pathway.

ECSP003814 2000-12-07 2000-12-07 INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY. ECSP003814A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003814 ECSP003814A (en) 2000-12-07 2000-12-07 INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003814 ECSP003814A (en) 2000-12-07 2000-12-07 INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.

Publications (1)

Publication Number Publication Date
ECSP003814A true ECSP003814A (en) 2001-04-23

Family

ID=42041366

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003814 ECSP003814A (en) 2000-12-07 2000-12-07 INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.

Country Status (1)

Country Link
EC (1) ECSP003814A (en)

Similar Documents

Publication Publication Date Title
UY26474A1 (en) AMINO ACID DEPENDENT INHIBITORS FOR BRANCHED CHAIN AMINO ACIDS, AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
DK1317419T3 (en) Cyanophenoxycarboxylic acid compounds and compositions to deliver active agents
DK1296670T3 (en) Therapeutic fatty acid combinations
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
DE60215787D1 (en) TREATMENT OF TYPE II DIABETES WITH DIPEPTIDYL PEPTIDASE IV INHIBITORS
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
ATE461698T1 (en) GABA ANALOGUES FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
EA200400966A1 (en) NEW MEDICATED FORMS OF SUBSTITUTED BENZIMIDAZOL AND METHOD OF THEIR APPLICATION
NO20063373L (en) CD40 antibody formulations and methods
TWI367751B (en) Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
MX9306295A (en) PHARMACEUTICAL COMPOSITIONS TO TREAT SYMPTOMS OF COLD.
DK1383540T3 (en) Methods and pharmaceutical compositions for wound healing
ATE337712T1 (en) COMPOSITION FOR INTESTINAL ADMINISTRATION
SE0202886D0 (en) Dermatological use and a dermatological preparation
DK1677806T3 (en) Compositions for the treatment of acute and congestion-induced sprains and stretching using hyaluronic acid
ATE324112T1 (en) TOPICAL TREATMENT FOR MASTALGIA
MXPA04011835A (en) Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent.
DE60011748D1 (en) METHODS AND COMPILATIONS FOR TREATING THE FEMALE SEXUAL DYSFUNCTION
MXPA05008403A (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms.
ECSP003814A (en) INHIBITORS OF AMINOTRANSPHERASE DEPENDENT OF AMINO ACIDS OF RAMIFIED CHAIN AND ITS USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
CL2004000767A1 (en) ORAL DOSING UNIT INCLUDING AN ANTAGONIST AGENT FOR PUMPS OF PROTONS AND EXCIPIENTS OF BASIC CHARACTER; PROCEDURE FOR PREPARATION, USEFUL TO TREAT DISEASES CAUSED BY AN INCREASED SECRETION OF GASTRIC ACIDS.
AU3737901A (en) Use of pde v inhibitors
WO2001055108A3 (en) Use of spl a2 inhibitors for the treatment of inflammation
AR048355A1 (en) ASSOCIATION BETWEEN A HETEROCICLICAL COMPOUND AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60130253D1 (en) COMPOSITIONS FOR PREVENTING ADHESION